Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


23.12.2018

1 Acta Ophthalmol
2 Am J Cardiol
2 Am J Ophthalmol
2 Ann Intern Med
2 Biochem Biophys Res Commun
1 BMJ
1 Circ Cardiovasc Qual Outcomes
3 Circulation
3 Diabet Med
3 Diabetes
28 Diabetes Care
5 Diabetes Educ
7 Diabetes Obes Metab
2 Diabetologia
3 Hypertension
1 J Clin Endocrinol Metab
1 J Diabetes Complications
1 Ophthalmology
3 Pediatr Diabetes
6 PLoS One
1 Stroke


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. GABRIELLE PH, Massin P, Kodjikian L, Erginay A, et al
    Central retinal thickness following panretinal photocoagulation using a multispot semi-automated pattern-scanning laser to treat ischaemic diabetic retinopathy: Treatment in one session compared with four monthly sessions.
    Acta Ophthalmol. 2018 Dec 18. doi: 10.1111/aos.14002.
    PubMed     Text format     Abstract available


    Am J Cardiol

  2. YEBOAH P, Hsu FC, Bertoni AG, Yeboah J, et al
    Body Mass Index, Change in Weight, Body Weight Variability and Outcomes in Type 2 Diabetes Mellitus (from the ACCORD Trial).
    Am J Cardiol. 2018 Dec 3. pii: S0002-9149(18)32097.
    PubMed     Text format     Abstract available

  3. NOUS FMA, Coenen A, Boersma E, Kim YH, et al
    Comparison of the Diagnostic Performance of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve in Patients With Versus Without Diabetes Mellitus (from the MACHINE Consortium).
    Am J Cardiol. 2018 Nov 24. pii: S0002-9149(18)32105.
    PubMed     Text format     Abstract available


    Am J Ophthalmol

  4. HAGENAU F, Vogt D, Ziada J, Guenther SR, et al
    Vitrectomy for diabetic macular edema: optical coherence tomography criteria and pathology of the vitreomacular interface.
    Am J Ophthalmol. 2018 Dec 14. pii: S0002-9394(18)30673.
    PubMed     Text format     Abstract available

  5. LIU R, Ma B, Gao Y, Ma B, et al
    Tear Inflammatory Cytokines Analysis and Clinical Correlations in Diabetes and Non-diabetes with Dry Eye.
    Am J Ophthalmol. 2018 Dec 12. pii: S0002-9394(18)30669.
    PubMed     Text format     Abstract available


    Ann Intern Med

  6. SANTULLI G
    In diabetes with no CVD, aspirin reduced serious vascular events but increased major bleeding at 7.4 years.
    Ann Intern Med. 2018;169:JC67.
    PubMed     Text format    


  7. Correction: Glycemic Targets for Older Adults With Type 2 Diabetes.
    Ann Intern Med. 2018;169:899.
    PubMed     Text format    


    Biochem Biophys Res Commun

  8. SHIN JS, Kim JM, Min BH, Chung H, et al
    Absence of spontaneous regeneration of endogenous pancreatic beta-cells after chemical-induced diabetes and no effect of GABA on alpha-to-beta cell transdifferentiation in rhesus monkeys.
    Biochem Biophys Res Commun. 2018 Dec 12. pii: S0006-291X(18)32705.
    PubMed     Text format     Abstract available

  9. ROMO-YANEZ J, Dominguez-Castro M, Flores-Reyes JS, Estrada-Juarez H, et al
    Hyperglycemia differentially affects proliferation, apoptosis, and BNIP3 and p53 mRNA expression of human umbilical cord Wharton's jelly cells from non-diabetic and diabetic pregnancies.
    Biochem Biophys Res Commun. 2018 Dec 13. pii: S0006-291X(18)32680.
    PubMed     Text format     Abstract available


    BMJ

  10. CHARLTON M
    Everyone with type 1 diabetes should have access to a flash glucose device.
    BMJ. 2018;363:k5204.
    PubMed     Text format    


    Circ Cardiovasc Qual Outcomes

  11. BANGALORE S, Fayyad R, DeMicco DA, Colhoun HM, et al
    Body Weight Variability and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004724.
    PubMed     Text format     Abstract available


    Circulation

  12. VERMA S, Poulter NR, Bhatt DL, Bain SC, et al
    Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
    Circulation. 2018;138:2884-2894.
    PubMed     Text format     Abstract available

  13. MANN JFE, Fonseca V, Mosenzon O, Raz I, et al
    Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease.
    Circulation. 2018;138:2908-2918.
    PubMed     Text format     Abstract available

  14. BJORNSTAD P, Schafer M, Truong U, Cree-Green M, et al
    Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus.
    Circulation. 2018;138:2895-2907.
    PubMed     Text format     Abstract available


    Diabet Med

  15. DANHAUER SC, Brenes GA, Levine BJ, Young L, et al
    Variability in sleep disturbance, physical activity and quality of life according to level of depressive symptoms in women with Type 2 diabetes.
    Diabet Med. 2018 Dec 15. doi: 10.1111/dme.13878.
    PubMed     Text format     Abstract available

  16. NUNLEY KA, Karp JF, Orchard TJ, Costacou T, et al
    Depressive symptoms and cerebral microvascular disease in adults with Type 1 diabetes mellitus.
    Diabet Med. 2018 Dec 15. doi: 10.1111/dme.13879.
    PubMed     Text format     Abstract available

  17. WALSH NA, O'Dea MI, O'Grady MJ
    The apparent low incidence of paediatric Type 2 diabetes in the Republic of Ireland is multifactorial.
    Diabet Med. 2018 Dec 15. doi: 10.1111/dme.13877.
    PubMed     Text format     Abstract available


    Diabetes

  18. KAWABATA Y, Nishida N, Awata T, Kawasaki E, et al
    A genome-Wide Association Study Confirming a Strong Effect of HLA and Identifying Variants in CSAD/lnc-ITGB7-1 on Chromosome 12q13.13 Associated with Susceptibility to Fulminant Type 1 Diabetes.
    Diabetes. 2018 Dec 14. pii: db18-0314. doi: 10.2337/db18-0314.
    PubMed     Text format     Abstract available

  19. LAM CJ, Chatterjee A, Shen E, Cox AR, et al
    Low Level Insulin Content Within Abundant Non-Beta Islet Endocrine Cells in Long-Standing Type 1 Diabetes.
    Diabetes. 2018 Dec 14. pii: db18-0305. doi: 10.2337/db18-0305.
    PubMed     Text format     Abstract available

  20. KATAYAMA M, Wiklander OPB, Fritz T, Caidahl K, et al
    Circulating Exosomal miR-20b-5p is Elevated in Type 2 Diabetes and Could Impair Insulin Action in Human Skeletal Muscle.
    Diabetes. 2018 Dec 14. pii: db18-0470. doi: 10.2337/db18-0470.
    PubMed     Text format     Abstract available


    Diabetes Care


  21. Summary of Revisions: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format    


  22. Professional Practice Committee: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format    


  23. Introduction: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format    

  24. BERGENSTAL RM, Beck RW, Close KL, Grunberger G, et al
    Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275-2280.
    Diabetes Care. 2018 Dec 17. pii: dci18-0061. doi: 10.2337/dci18-0061.
    PubMed     Text format    

  25. PLUCHINO KM, Wu Y, Silk AD, Yi J, et al
    Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275-2280.
    Diabetes Care. 2018 Dec 17. pii: dc18-2366. doi: 10.2337/dc18-2366.
    PubMed     Text format    

  26. VIROSTKO J, Williams J, Hilmes M, Bowman C, et al
    Pancreas Volume Declines During the First Year After Diagnosis of Type 1 Diabetes and Exhibits Altered Diffusion at Disease Onset.
    Diabetes Care. 2018 Dec 14. pii: dc18-1507. doi: 10.2337/dc18-1507.
    PubMed     Text format     Abstract available

  27. LACLAUSTRA M, Moreno-Franco B, Lou-Bonafonte JM, Mateo-Gallego R, et al
    Impaired Sensitivity to Thyroid Hormones Is Associated With Diabetes and Metabolic Syndrome.
    Diabetes Care. 2018 Dec 14. pii: dc18-1410. doi: 10.2337/dc18-1410.
    PubMed     Text format     Abstract available

  28. KOWALL B, Rathmann W, Bongaerts B, Kuss O, et al
    Incidence Rates of Type 2 Diabetes in People With Impaired Fasting Glucose (ADA vs. WHO Criteria) and Impaired Glucose Tolerance: Results From an Older Population (KORA S4/F4/FF4 Study).
    Diabetes Care. 2018 Dec 14. pii: dc18-1473. doi: 10.2337/dc18-1473.
    PubMed     Text format    

  29. VLOEMANS AF, Eilander MMA, Rotteveel J, Bakker-van Waarde WM, et al
    Youth With Type 1 Diabetes Taking Responsibility for Self-Management: The Importance of Executive Functioning in Achieving Glycemic Control: Results From the Longitudinal DINO Study.
    Diabetes Care. 2018 Dec 14. pii: dc18-1143. doi: 10.2337/dc18-1143.
    PubMed     Text format     Abstract available

  30. THORN LM, Shams S, Gordin D, Liebkind R, et al
    Clinical and MRI Features of Cerebral Small-Vessel Disease in Type 1 Diabetes.
    Diabetes Care. 2018 Dec 14. pii: dc18-1302. doi: 10.2337/dc18-1302.
    PubMed     Text format     Abstract available

  31. CAMPBELL-THOMPSON ML, Filipp SL, Grajo JR, Nambam B, et al
    Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes.
    Diabetes Care. 2018 Dec 14. pii: dc18-1512. doi: 10.2337/dc18-1512.
    PubMed     Text format     Abstract available


  32. 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  33. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  34. 3. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  35. 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  36. Disclosures: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format    


  37. 16. Diabetes Advocacy: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  38. 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  39. 13. Children and Adolescents: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  40. 12. Older Adults: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  41. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  42. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  43. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  44. 5. Lifestyle Management: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  45. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  46. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  47. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


  48. 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019.
    Diabetes Care. 2019;42.
    PubMed     Text format     Abstract available


    Diabetes Educ

  49. GUTIERREZ AP, Fortmann AL, Savin K, Clark TL, et al
    Effectiveness of Diabetes Self-Management Education Programs for US Latinos at Improving Emotional Distress: A Systematic Review.
    Diabetes Educ. 2018 Dec 20:145721718819451. doi: 10.1177/0145721718819451.
    PubMed     Text format     Abstract available

  50. BECK J, Greenwood DA, Blanton L, Bollinger ST, et al
    2017 National Standards for Diabetes Self-Management Education and Support.
    Diabetes Educ. 2018 Dec 17:145721718820941. doi: 10.1177/0145721718820941.
    PubMed     Text format     Abstract available


  51. Role of the Diabetes Educator in Inpatient Diabetes Management.
    Diabetes Educ. 2018 Dec 17:145721718820944. doi: 10.1177/0145721718820944.
    PubMed     Text format     Abstract available


  52. Management of Children With Diabetes in the School Setting.
    Diabetes Educ. 2018 Dec 17:145721718820943. doi: 10.1177/0145721718820943.
    PubMed     Text format     Abstract available


  53. The Role of the Diabetes Educator in Diabetes Formulary and Medical Device Decisions.
    Diabetes Educ. 2018 Dec 17:145721718820942. doi: 10.1177/0145721718820942.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  54. HEISE T, Meiffren G, Alluis B, Seroussi C, et al
    BioChaperone Lispro (BCLIS) vs faster aspart (FIA) and insulin aspart (ASP) in patients with type 1 diabetes on continuous subcutaneous insulin infusion: a randomized euglycemic clamp study.
    Diabetes Obes Metab. 2018 Dec 18. doi: 10.1111/dom.13621.
    PubMed     Text format     Abstract available

  55. PAWASKAR M, Pinar Bilir S, Kowal S, Gonzalez C, et al
    Cost-effectiveness of intensification with SGLT2i in Type 2 Diabetes patients on metformin and sitagliptin compared to direct intensification with insulin in the United Kingdom.
    Diabetes Obes Metab. 2018 Dec 18. doi: 10.1111/dom.13618.
    PubMed     Text format     Abstract available

  56. CHEN W, Zhou Y, Kong Z, Wang X, et al
    The Renoprotective Effects of SGLT2 Inhibitors versus Placebo in Patients with Type 2 Diabetes with or without Prevalent Kidney Disease: A Systematic Review and Meta-analysis.
    Diabetes Obes Metab. 2018 Dec 18. doi: 10.1111/dom.13620.
    PubMed     Text format     Abstract available

  57. SINGH P, Pesavento TE, Washburn K, Walsh D, et al
    Largest single-center experience of dulaglutide for the management of diabetes mellitus in solid organ transplant.
    Diabetes Obes Metab. 2018 Dec 18. doi: 10.1111/dom.13619.
    PubMed     Text format     Abstract available

  58. RETNAKARAN R, Ye C, Kramer CK
    Stability of Insulin and C-peptide Measurement with Long-term Frozen Storage of Serum: Implications for Diabetes Research Studies.
    Diabetes Obes Metab. 2018 Dec 18. doi: 10.1111/dom.13617.
    PubMed     Text format     Abstract available

  59. HOLMES RS, Crabtree E, McDonagh MS
    Comparative effectiveness and harms of long-acting insulins for Type 1 and Type 2 diabetes: a systematic review and meta-analysis.
    Diabetes Obes Metab. 2018 Dec 15. doi: 10.1111/dom.13614.
    PubMed     Text format     Abstract available

  60. TIBALDI J, Hadley-Brown M, Liebl A, Haldrup S, et al
    A comparative effectiveness study of degludec and insulin glargine 300U/mL in insulin-naive patients with type 2 diabetes.
    Diabetes Obes Metab. 2018 Dec 15. doi: 10.1111/dom.13616.
    PubMed     Text format     Abstract available


    Diabetologia

  61. LAWRENCE JM, Mayer-Davis EJ
    What do we know about the trends in incidence of childhood-onset type 1 diabetes?
    Diabetologia. 2018 Dec 19. pii: 10.1007/s00125-018-4791.
    PubMed     Text format    

  62. PERDIGOTO AL, Preston-Hurlburt P, Clark P, Long SA, et al
    Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis.
    Diabetologia. 2018 Dec 19. pii: 10.1007/s00125-018-4786.
    PubMed     Text format     Abstract available


    Hypertension

  63. OHKUMA T, Jun M, Rodgers A, Cooper ME, et al
    Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus.
    Hypertension. 2019;73:84-91.
    PubMed     Text format     Abstract available

  64. COLLARD D, Brouwer TF, Peters RJG, Vogt L, et al
    Creatinine Rise During Blood Pressure Therapy and the Risk of Adverse Clinical Outcomes in Patients With Type 2 Diabetes Mellitus.
    Hypertension. 2018;72:1337-1344.
    PubMed     Text format     Abstract available

  65. MIRANDA JO, Cerqueira RJ, Barros H, Areias JC, et al
    Maternal Diabetes Mellitus as a Risk Factor for High Blood Pressure in Late Childhood.
    Hypertension. 2019;73:e1-e7.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  66. MAROTT SCW, Nordestgaard BG, Tybjaerg-Hansen A, Benn M, et al
    Causal associations in type 2 diabetes development.
    J Clin Endocrinol Metab. 2018 Dec 19. pii: 5251730. doi: 10.1210/jc.2018-01648.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  67. WYSHAM CH, Lefebvre P, Pilon D, Lafeuille MH, et al
    An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical records.
    J Diabetes Complications. 2018 Oct 31. pii: S1056-8727(18)30329.
    PubMed     Text format     Abstract available


    Ophthalmology

  68. SAYRES R, Taly A, Rahimy E, Blumer K, et al
    Using a deep learning algorithm and integrated gradients explanation to assist grading for diabetic retinopathy.
    Ophthalmology. 2018 Nov 28. pii: S0161-6420(18)31575.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  69. DUCA LM, Reboussin BA, Pihoker C, Imperatore G, et al
    Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes and Glycemic Control over Time: The SEARCH for Diabetes in Youth Study.
    Pediatr Diabetes. 2018 Dec 17. doi: 10.1111/pedi.12809.
    PubMed     Text format     Abstract available

  70. BUCHANAN K, Mehdi AM, Hughes I, Cotterill A, et al
    An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetes.
    Pediatr Diabetes. 2018 Dec 17. doi: 10.1111/pedi.12808.
    PubMed     Text format     Abstract available

  71. ELLIS DA, Carcone A, Slatcher R, Naar-King S, et al
    Efficacy of Mindfulness-Based Stress Reduction in Emerging Adults with Poorly Controlled, Type 1 Diabetes: A Pilot Randomized Controlled Trial.
    Pediatr Diabetes. 2018 Dec 15. doi: 10.1111/pedi.12807.
    PubMed     Text format     Abstract available


    PLoS One

  72. PABALAN N, Tiongco RE, Pandac JK, Paragas NA, et al
    Association and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysis.
    PLoS One. 2018;13:e0208905.
    PubMed     Text format     Abstract available

  73. SKRTIC S, Tyrberg B, Broberg M, Ericsson H, et al
    Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.
    PLoS One. 2018;13:e0208998.
    PubMed     Text format     Abstract available

  74. GUALERZI A, Bellan M, Smirne C, Tran Minh M, et al
    Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents.
    PLoS One. 2018;13:e0209216.
    PubMed     Text format     Abstract available

  75. CECCHINI M, Smith P
    Assessing the dose-response relationship between number of office-based visits and hospitalizations for patients with type II diabetes using generalized propensity score matching.
    PLoS One. 2018;13:e0209197.
    PubMed     Text format     Abstract available

  76. TANAKA S, Kanazawa I, Sugimoto T
    Nerve conduction velocity is negatively associated with intima-media thickness and brachial-ankle pulse wave velocity in men with type 2 diabetes mellitus.
    PLoS One. 2018;13:e0209503.
    PubMed     Text format     Abstract available

  77. TAIRA M, Imamura M, Takahashi A, Kamatani Y, et al
    A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.
    PLoS One. 2018;13:e0208654.
    PubMed     Text format     Abstract available


    Stroke

  78. JIANG Y, Liu N, Wang Q, Yu Z, et al
    Endocrine Regulator rFGF21 (Recombinant Human Fibroblast Growth Factor 21) Improves Neurological Outcomes Following Focal Ischemic Stroke of Type 2 Diabetes Mellitus Male Mice.
    Stroke. 2018;49:3039-3049.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: